Φιλτράρισμα ανά Last updated date SelectΜετάΠρινFrom - To Date Ημερομηνία λήξης This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationMedicine shortagesResearch and developmentBiosimilarsSMEAntimicrobial resistanceCorporateGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate usePRIMECareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety information Patient safety Leave this field blank Filter Αποτελέσματα (3838) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank EMEA public statement on Replaglinide (NovoNorm/Prandin) contraindication of concomitant use of Replaglinide and Gemfibrozil 21 Μάιος 2003News Committee for veterinary medicinal products: Meeting of 13 to 14 May 2003 15 Μάιος 2003Press releaseVeterinary 35th meeting of the Committee for Orphan Medicinal Products 12 Μάιος 2003Press releaseHumanRare diseases European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 23 to 25 April 2003 28 Απρίλιος 2003Press release Metabolic and cardiovascular complications of antiretroviral combination therapy in HIV-infected patients 25 Απρίλιος 2003News 34th meeting of the Committee for Orphan Medicinal Products 16 Απρίλιος 2003Press releaseHumanRare diseases Committee for veterinary medicinal products: Meeting of 8 to 9 April 2003 11 Απρίλιος 2003Press releaseVeterinary EU enlargement countries to join EMEA as observers from 1 April 2003 31 Μάρτιος 2003Press release Meeting of the EMEA working party on herbal medicinal products 24 - 25 February 2003 28 Μάρτιος 2003Press releaseHerbal 33rd meeting of the Committee for Orphan Medicinal Products 24 Μάρτιος 2003Press releaseHumanRare diseases 1 … 350 351 352 353 354 Page 354 of 384 355 356 357 358 … 384
EMEA public statement on Replaglinide (NovoNorm/Prandin) contraindication of concomitant use of Replaglinide and Gemfibrozil 21 Μάιος 2003News
Committee for veterinary medicinal products: Meeting of 13 to 14 May 2003 15 Μάιος 2003Press releaseVeterinary
35th meeting of the Committee for Orphan Medicinal Products 12 Μάιος 2003Press releaseHumanRare diseases
European Agency for the evaluation of medicinal products: Committee for Proprietary Medicinal Products, meeting of 23 to 25 April 2003 28 Απρίλιος 2003Press release
Metabolic and cardiovascular complications of antiretroviral combination therapy in HIV-infected patients 25 Απρίλιος 2003News
34th meeting of the Committee for Orphan Medicinal Products 16 Απρίλιος 2003Press releaseHumanRare diseases
Committee for veterinary medicinal products: Meeting of 8 to 9 April 2003 11 Απρίλιος 2003Press releaseVeterinary
Meeting of the EMEA working party on herbal medicinal products 24 - 25 February 2003 28 Μάρτιος 2003Press releaseHerbal
33rd meeting of the Committee for Orphan Medicinal Products 24 Μάρτιος 2003Press releaseHumanRare diseases